The present invention relates to an ophthalmic aqueous solution for treating ocular hypertension and glaucoma, comprising tafluprost as an active ingredient, nonionic surfactant, stabilizing agent and substantially no preservatives in a single dose or unit dose container consisting essentially of polyethylene.